Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised

Submitted by Anonymous (not verified) on 5 November 2024 - 14:36

Veterinary medicines European public assessment report (EPAR): Hiprabovis IBR Marker Live, live gene-deleted vaccine for intramuscular use for active immunisation of cattle against infectious bovine rhinotracheitis, Status: Authorised

Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Date of authorisation: 17/12/2008, Revision: 28, Status: Authorised

Submitted by Anonymous (not verified) on 5 November 2024 - 13:00

Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Date of authorisation: 17/12/2008, Revision: 28, Status: Authorised

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 12:00 (CEST)

Submitted by Anonymous (not verified) on 5 November 2024 - 10:38

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 September 2024, 10:00 (CEST) to 18 September 2024, 12:00 (CEST)

Submitted by Anonymous (not verified) on 5 November 2024 - 10:25

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 18 September 2024, 10:00 (CEST) to 18 September 2024, 12:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More